Willett, Christopher G.

Biomarkers of response and resistance to antiangiogenic therapy

Jain, R. K., Duda, D. G., Willett, C. G., Sahani, D. V., Zhu, A. X., Loeffler, J. S., Batchelor, T. T., & Sorensen, A. G. (2009) · Nature Reviews Clinical Oncology

Angiogenesis and VEGF in CancerColorectal Cancer Treatments and Studies

Cited by 572

Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy

Jung, K., Heishi, T., Khan, O. F., Kowalski, P. S., Incio, J., Rahbari, N. N., Chung, E., Clark, J. W., Willett, C. G., Luster, A. D., et al. (2017) · Journal of Clinical Investigation

Immune cells in cancerAngiogenesis and VEGF in Cancer

Cited by 164

Targeting CXCR4-dependent immunosuppressive Ly6C low monocytes improves antiangiogenic therapy in colorectal cancer

Jung, K., Heishi, T., Incio, J., Huang, Y., Beech, E. Y., Pinter, M., Ho, W. W., Kawaguchi, K., Rahbari, N. N., Chung, E., et al. (2017) · Proceedings of the National Academy of Sciences

Angiogenesis and VEGF in CancerChemokine receptors and signaling

Cited by 138

An Interpretable Planning Bot for Pancreas Stereotactic Body Radiation Therapy

Zhang, J., Wang, C., Sheng, Y., Palta, M., Czito, B., Willett, C., Zhang, J., Jensen, P. J., Yin, F.-F., Wu, Q., et al. (2021) · International Journal of Radiation Oncology*Biology*Physics

Advanced Radiotherapy TechniquesArtificial Intelligence in Healthcare and Education

Cited by 41